Literature DB >> 16020592

In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte.

R Zahn1, A Vogt, U Zeymer, A K Gitt, K Seidl, M Gottwik, M A Weber, W Niederer, B Mödl, H-J Engel, U Tebbe, J Senges.   

Abstract

OBJECTIVE: To determine the predictors of time between presentation and primary angioplasty and the influence of this delay time on in-hospital mortality in clinical practice.
DESIGN: Analysis of data from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK). PATIENTS: Data of 4815 patients registered at 80 hospitals between 1994 and 2000 were analysed.
RESULTS: Mean age of the patients was 61.4 (12.5) years. Cardiogenic shock was present in 14.1%. Mean time from admission to primary angioplasty ("door to angiography" time) was 83 (122) minutes. Logistic regression analysis showed the presence of a bundle branch block (odds ratio (OR) 1.95, 95% confidence interval (CI) 1.15 to 3.29), prior coronary artery bypass grafting (OR 1.67, 95% CI 1.08 to 2.59), pre-hospital delay > 3 hours (OR 1.61, 95% CI 1.37 to 1.89), and female sex (OR 1.21, 95% CI 1.01 to 1.45) to be independently associated with longer door to angiography times, whereas a higher hospital volume of performing primary angioplasty (OR 0.53, 95% CI 0.46 to 0.62) and the year of the investigation (OR 0.96, 95% CI 0.92 to 1.00) were independently associated with shorter door to angiography times. Independent predictors of in-hospital mortality were cardiogenic shock (41.6% v 4.0% without cardiogenic shock, p < 0.0001), technical success (29.2% with TIMI (thrombolysis in myocardial infarction) flow < 3 v 6.5% with TIMI flow 3, p < 0.0001), age (16.5% > or = 70 years v 6.6% < 70, p < 0.0001), three vessel disease (16.5% v 6.8% with < 3 vessel disease, p < 0.0001), anterior location of infarction (12% v 7.4% without anterior infarction, p < 0.0001), year of inclusion (adjusted OR 0.92 per year, p = 0.011), and volume of primary angioplasty at the hospital (11% for < 20 angioplasty procedures/year v 8.3% for > or = 20/year, p = 0.027) but not the door to angiography time (adjusted OR 1.14 per tertile, p = 0.397).
CONCLUSIONS: In current clinical practice in Germany median door to angiography time is quite short (83 (122) minutes). Some patients and hospital factors are independently associated with a longer door to angiography time. Within the observed short in-hospital delays door to angiography time did not influence in-hospital mortality. However, efforts to keep them as short as possible should be continued.

Entities:  

Mesh:

Year:  2005        PMID: 16020592      PMCID: PMC1769038          DOI: 10.1136/hrt.2004.045336

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

1.  Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra; A Patel; M Jones; C L Grines; S Ellis; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; F Ribichini; C Granger; F Akhras; W D Weaver; R J Simes
Journal:  Eur Heart J       Date:  2002-04       Impact factor: 29.983

2.  Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis.

Authors:  R Zahn; R Schiele; A K Gitt; S Schneider; K Seidl; T Voigtländer; M Gottwik; E Altmann; U Gieseler; W Rosahl; S Wagner; J Senges
Journal:  Am Heart J       Date:  2001-07       Impact factor: 4.749

3.  Predictors of door-to-balloon delay in primary angioplasty.

Authors:  Brad G Angeja; C Michael Gibson; Richard Chin; Paul D Frederick; Nathan R Every; Allan M Ross; Gregg W Stone; Hal V Barron
Journal:  Am J Cardiol       Date:  2002-05-15       Impact factor: 2.778

4.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

Authors:  C P Cannon; C M Gibson; C T Lambrew; D A Shoultz; D Levy; W J French; J M Gore; W D Weaver; W J Rogers; A J Tiefenbrunn
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

5.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

Authors:  P Widimský; T Budesínský; D Vorác; L Groch; M Zelízko; M Aschermann; M Branny; J St'ásek; P Formánek
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

6.  Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

Authors:  Giuseppe De Luca; Harry Suryapranata; Felix Zijlstra; Arnoud W J van 't Hof; Jan C A Hoorntje; A T Marcel Gosselink; Jan Henk Dambrink; Menko Jan de Boer
Journal:  J Am Coll Cardiol       Date:  2003-09-17       Impact factor: 24.094

Review 7.  Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.

Authors:  C Grines; A Patel; F Zijlstra; W D Weaver; C Granger; R J Simes
Journal:  Am Heart J       Date:  2003-01       Impact factor: 4.749

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis.

Authors:  Albert Schömig; Gjin Ndrepepa; Julinda Mehilli; Markus Schwaiger; Helmut Schühlen; Stephan Nekolla; Jürgen Pache; Stefan Martinoff; Hildegard Bollwein; Adnan Kastrati
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

10.  Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time.

Authors:  Jean-Michel Juliard; Laurent J Feldman; Jean-Louis Golmard; Dominique Himbert; Hakim Benamer; Tinouche Haghighat; Daniel Karila-Cohen; Pierre Aubry; Alec Vahanian; Ph Gabriel Steg
Journal:  Am J Cardiol       Date:  2003-06-15       Impact factor: 2.778

View more
  12 in total

1.  Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers.

Authors:  Robert M Minutello; Luke Kim; Smita Aggarwal; Linda J Cuomo; Dmitriy N Feldman; S Chiu Wong
Journal:  Tex Heart Inst J       Date:  2010

2.  Primary percutaneous coronary intervention in acute myocardial infarction: time, time, and time!

Authors:  P G Steg; J-M Juliard
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

Review 3.  [Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only].

Authors:  Ralf Zahn; Uwe Zeymer
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

4.  Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories.

Authors:  Patricia Krüth; Uwe Zeymer; Anselm Gitt; Claus Jünger; Harm Wienbergen; Franz Niedermeier; Hans-Georg Glunz; Jochen Senges; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2008-05-08       Impact factor: 5.460

5.  As time goes by?: the fallacy of thrombolysis in STEMI networks.

Authors:  Wolfgang von Scheidt; Christian Thilo
Journal:  Clin Res Cardiol       Date:  2011-06-30       Impact factor: 5.460

Review 6.  German chest pain unit registry: data review after the first decade of certification.

Authors:  Frank Breuckmann; Tienush Rassaf; Matthias Hochadel; Evangelos Giannitsis; Thomas Münzel; Jochen Senges
Journal:  Herz       Date:  2020-03-30       Impact factor: 1.443

7.  Short-term prognosis of contemporary interventional therapy of ST-elevation myocardial infarction: does gender matter?

Authors:  Stefan Zimmermann; Susanne Ruthrof; Kathrin Nowak; Anna Alff; Lutz Klinghammer; Reinhard Schneider; Josef Ludwig; Annette B Pfahlberg; Werner G Daniel; Frank A Flachskampf
Journal:  Clin Res Cardiol       Date:  2009-08-19       Impact factor: 5.460

8.  Efficacy and limitations of a STEMI network: 3 years of experience within the myocardial infarction network of the region of Augsburg - HERA.

Authors:  Christian Thilo; Andreas Blüthgen; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2013-09-06       Impact factor: 5.460

9.  Preprocedural TIMI flow and infarct size in STEMI undergoing primary angioplasty.

Authors:  Giuseppe De Luca; Guido Parodi; Roberto Sciagrà; Francesco Venditti; Benedetta Bellandi; Ruben Vergara; Angela Migliorini; Renato Valenti; David Antoniucci
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

10.  Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems.

Authors:  J Lázár; T Szabó; L Kovács; P M Blumberg; T Bíró
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.